IP Library Granted Patent US 11,045,440
Granted Patent B2
US 11,045,440 · App. 16/287,543 · Granted Jun 29, 2021

Enteral feeding devices and related methods of use

Inventors: Robert Gallotto (Medway, MA); Greta L. Loring (Wakefield, MA); Kenneth Gary (Boxborough, MA); Edward S. Park (Southborough, MA); David J. Brown (Brookline, MA); Willem Robert Klaas Schoevaart (Delft, NL); Michiel Christian Alexander van Vliet (Delft, NL)
Assignee: Alcresta Therapeutics, Inc.
A61K31/202A23L33/00A23L33/12A23L33/40A61J15/0076A61L29/048A61M5/14A61M5/142A61M5/1413C12N9/20C12N11/06C12N11/08
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,440
App. No.
16/287,543
Granted
Jun 29, 2021
Kind
B2
Abstract

Embodiments of the disclosure are drawn to an enteral feeding device for hydrolyzing triglycerides in a nutritional formula. The device may include a body housing a chamber, an inlet configured to fluidly couple with a source of nutritional formula, and an outlet configured to fluidly couple with an enteral feeding tube. The device may include a headspace and a plurality of particles contained within the chamber, wherein the lipase is covalently bonded to the plurality of particles. The device may include an inlet filter located between the inlet and the chamber, wherein the inlet filter contains a first plurality of openings, and an outlet filter located between the chamber and the outlet, wherein the outlet filter has a second plurality of openings smaller than the plurality of particles.

Claims (23)

1. An enteral feeding device comprising:

a body housing a chamber;

one or more particles contained within the chamber, wherein lipase is bonded to the one or more particles;

wherein the one or more particles are configured to transition from a dry configuration to a wet configuration when exposed to a nutritional formula; and

wherein, in the dry configuration, the one or more particles have a moisture level of 0.1% to 5%, and wherein, in the wet configuration, the one or more particles swell in volume by no more than 15%.

2. The device of claim 1 , wherein the one or more particles, when dry, fill at least 50% of the chamber.

3. The device of claim 1 , wherein the one or more particles, when dry, fill at least 80% of the chamber.

4. The device of claim 1 , wherein the one or more particles, when dry, fill at least 90% of the chamber.

5. The device of claim 1 , wherein the one or more particles, when exposed to the nutritional formula, fill at least 80% of the chamber.

6. The device of claim 1 , wherein the one or more particles, when exposed to the nutritional formula, fill at least 90% of the chamber.

7. The device of claim 1 , wherein the device further comprises an inlet in fluid communication with the chamber for receiving the nutritional formula.

8. The device of claim 1 , wherein an outside surface of at least one of the one or more particles is at least partially hydrophobic.

9. The device of claim 1 , wherein at least one of the one or more particles is formed of at least one of ethylene glycol dimethacrylate, butyl methacrylate, or glycidyl methacrylate.

10. The device of claim 1 , wherein at least one of the one or more particles is formed of 0% to 10% of polyethylene glycol by weight.

11. The device of claim 1 , wherein at least one of the one or more particles has a porous cross-section forming internal surfaces within the at least one particle, and wherein the lipase is bonded to the internal surfaces.

12. The device of claim 11 , wherein a median or a mean diameter of a pore of the porous cross-section ranges from 10 nm to 250 nm.

13. The device of claim 1 , wherein at least one of an outer surface or an internal surface of at least one of the one or more particles includes a functional group.

14. The device of claim 13 , wherein the functional group is an epoxy group, and the lipase is bonded to the epoxy group.

15. The device of claim 1 , wherein the one or more particles comprises a first group of particles and a second group of particles, wherein the first group of particles has a median or a mean diameter that is different than a median or a mean diameter of the second group of particles.

16. The device of claim 1 , wherein an amount of the lipase bonded to the one or more particles falls within a range of 50 mg to 250 mg of lipase per 1 g of the one or more particles.

17. The device of claim 1 , further comprising an inlet and an inlet filter, wherein the inlet filter is coated with at least one emulsifier configured to emulsify the nutritional formula.

18. The device of claim 1 , wherein the lipase bonded to the one or more particles is a phospholipase.

19. The device of claim 1 , wherein the one or more particles have an average diameter of 250 μm to 800 μm.

Assignments (6)
SECURITY INTEREST Recorded Mar 12, 2024
From: ALCRESTA THERAPEUTICS, INC.
To: TWIN BROOK CAPITAL PARTNERS, LLC, AS AGENT
Reel/Frame 066742/0319 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT (PATENTS) AT REEL/FRAME: 058415/0114 Recorded Mar 12, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 066799/0356 →
SECURITY INTEREST Recorded Dec 17, 2021
From: ALCRESTA THERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 058415/0114 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 28, 2019
From: CHIRALVISION B.V.
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 049297/0940 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: SCHOEVAART, WILLEM ROBERT KLAAS; VAN VLIET, MICHIEL CHRISTIAN ALEXANDER
To: CHIRALVISION B.V.
Reel/Frame 049100/0876 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2019
From: GALLOTTO, ROBERT; LORING, GRETA L; GARY, KENNETH; PARK, EDWARD S; BROWN, DAVID J
To: ALCRESTA THERAPEUTICS, INC.
Reel/Frame 049100/0912 →
Continuity (3)
Continuation 15291530 · Oct 12, 2016
Provisional Application 62241608 · Oct 14, 2015
Related Publication 20190224155A1 · Jul 25, 2019